Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2025-09-26 Director's Dealing
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare ASA: Mandatory notification of trade - Attachment: PDMR Attachment.pdf
Director's Dealing Classification · 1% confidence The document is a KRT-1500 template, which is the standard regulatory form used in Norway for the notification of transactions by persons discharging managerial responsibilities (PDMR) and persons closely associated with them. The content details a specific transaction (a forced sale of shares) involving a PDMR (CEO Joacim Holter) and a closely associated legal entity (Cimter AS). This falls directly under the definition of 'Director's Dealing' (DIRS), which covers insider trades and transactions by company executives.
2025-09-26 English
Lifecare ASA: Mandatory notification of trade - Attachment: Lifecare ASA- Mandatory notification of trade.pdf
Director's Dealing Classification · 1% confidence The document is titled 'MANDATORY NOTIFICATION OF TRADE' and explicitly references a 'PDMR-form' (Person Discharging Managerial Responsibilities). This is a standard regulatory disclosure for insider trading or director dealings under the Market Abuse Regulation (MAR). Since it reports a personal share transaction by a company executive, it falls under the 'Director's Dealing' category.
2025-09-26 English
Lifecare ASA: Mandatory notification of trade
Director's Dealing Classification · 1% confidence The document is titled 'Mandatory notification of trade' and references a 'PDMR-form' (Person Discharging Managerial Responsibilities). This is a standard regulatory disclosure for insider transactions by company executives. Under the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2025-09-26 English
Lifecare strengthens miniaturisation roadmap with new patent applications - Attachment: Lifecare strengthens miniaturisation roadmap with new patent applications.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing new patent applications for Lifecare ASA's sensor technology. It does not fit into financial reporting categories like 10-K, IR, or ER, nor does it announce the publication of a report (RPA). As it is a general corporate announcement regarding business operations and intellectual property that does not fall into specific categories like M&A or Board changes, it is classified as a general regulatory filing.
2025-09-24 English
Lifecare strengthens miniaturisation roadmap with new patent applications
Regulatory Filings Classification · 1% confidence The document is a press release announcing new patent applications for Lifecare ASA's sensor technology. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement (RPA) as it describes the content of the patent filing itself rather than just announcing the availability of a financial report. As it is a general corporate announcement regarding business operations and intellectual property that does not fall into the other specialized categories, it is best classified as a Regulatory Filing (RNS).
2025-09-24 English
LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY - Attachment: LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY.pdf
Regulatory Filings Classification · 1% confidence The document is a press release from Lifecare ASA announcing the resubmission of an application for a clinical study to the Norwegian Medical Products Agency. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement (RPA) as it describes a specific operational event. As it is a general corporate announcement regarding regulatory progress, it falls under the fallback category of Regulatory Filings (RNS).
2025-09-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.